Per an announcement on July 26, "MRSSI, Inc. announced today that Daniel P. van Kammen MD, PhD has joined as Chief Medical Officer. As such he will be responsible for the clinical development efforts of CHDI, Inc. CHDI was established in 2003 as a non-profit entity pursuing a biotech approach to finding therapies for Huntington disease (HD)".
Read more...